Search results for the GEO ID: GSE31245
(Click on the check boxes provided under "Select for analysis", to initiate grouping)
(Once the selection is made, click on "Add groups" in "Make groups for comparison", to make a group. Scroll down)
GSM ID
GPL ID
Select for analysis
Title
Source name
Description
Characteristics
GSM774516
GPL8300
Ovarian cancer sample 1 Ovarian cancer overall survival (months): 36 overall survival (censored 1=event)): 1
GSM774517
GPL8300
Ovarian cancer sample 2 Ovarian cancer overall survival (months): 35 overall survival (censored 1=event)): 0
GSM774518
GPL8300
Ovarian cancer sample 3 Ovarian cancer overall survival (months): 41 overall survival (censored 1=event)): 0
GSM774519
GPL8300
Ovarian cancer sample 4 Ovarian cancer overall survival (months): 66 overall survival (censored 1=event)): 0
GSM774520
GPL8300
Ovarian cancer sample 5 Ovarian cancer overall survival (months): 41 overall survival (censored 1=event)): 1
GSM774521
GPL8300
Ovarian cancer sample 6 Ovarian cancer overall survival (months): 48 overall survival (censored 1=event)): 1
GSM774522
GPL8300
Ovarian cancer sample 7 Ovarian cancer overall survival (months): 12 overall survival (censored 1=event)): 1
GSM774523
GPL8300
Ovarian cancer sample 8 Ovarian cancer overall survival (months): 59 overall survival (censored 1=event)): 0
GSM774524
GPL8300
Ovarian cancer sample 9 Ovarian cancer overall survival (months): 41 overall survival (censored 1=event)): 1
GSM774525
GPL8300
Ovarian cancer sample 10 Ovarian cancer overall survival (months): 73 overall survival (censored 1=event)): 0
GSM774526
GPL8300
Ovarian cancer sample 11 Ovarian cancer overall survival (months): 63 overall survival (censored 1=event)): 1
GSM774527
GPL8300
Ovarian cancer sample 12 Ovarian cancer overall survival (months): 19 overall survival (censored 1=event)): 1
GSM774528
GPL8300
Ovarian cancer sample 13 Ovarian cancer overall survival (months): 26 overall survival (censored 1=event)): 0
GSM774529
GPL8300
Ovarian cancer sample 14 Ovarian cancer overall survival (months): 23 overall survival (censored 1=event)): 0
GSM774530
GPL8300
Ovarian cancer sample 15 Ovarian cancer overall survival (months): 22 overall survival (censored 1=event)): 0
GSM774531
GPL8300
Ovarian cancer sample 16 Ovarian cancer overall survival (months): 52 overall survival (censored 1=event)): 0
GSM774532
GPL8300
Ovarian cancer sample 17 Ovarian cancer overall survival (months): 30 overall survival (censored 1=event)): 1
GSM774533
GPL8300
Ovarian cancer sample 18 Ovarian cancer overall survival (months): 50 overall survival (censored 1=event)): 1
GSM774534
GPL8300
Ovarian cancer sample 19 Ovarian cancer overall survival (months): 68 overall survival (censored 1=event)): 0
GSM774535
GPL8300
Ovarian cancer sample 20 Ovarian cancer overall survival (months): 46 overall survival (censored 1=event)): 1
GSM774536
GPL8300
Ovarian cancer sample 21 Ovarian cancer overall survival (months): 30 overall survival (censored 1=event)): 1
GSM774537
GPL8300
Ovarian cancer sample 22 Ovarian cancer overall survival (months): 34 overall survival (censored 1=event)): 1
GSM774538
GPL8300
Ovarian cancer sample 23 Ovarian cancer overall survival (months): 24 overall survival (censored 1=event)): 1
GSM774539
GPL8300
Ovarian cancer sample 24 Ovarian cancer overall survival (months): 39 overall survival (censored 1=event)): 0
GSM774540
GPL8300
Ovarian cancer sample 25 Ovarian cancer overall survival (months): 33 overall survival (censored 1=event)): 0
GSM774541
GPL8300
Ovarian cancer sample 26 Ovarian cancer overall survival (months): 57 overall survival (censored 1=event)): 0
GSM774542
GPL8300
Ovarian cancer sample 27 Ovarian cancer overall survival (months): 57 overall survival (censored 1=event)): 0
GSM774543
GPL8300
Ovarian cancer sample 28 Ovarian cancer overall survival (months): 69 overall survival (censored 1=event)): 0
GSM774544
GPL8300
Ovarian cancer sample 29 Ovarian cancer overall survival (months): 25 overall survival (censored 1=event)): 1
GSM774545
GPL8300
Ovarian cancer sample 30 Ovarian cancer overall survival (months): 74 overall survival (censored 1=event)): 0
GSM774546
GPL8300
Ovarian cancer sample 31 Ovarian cancer overall survival (months): 42 overall survival (censored 1=event)): 1
GSM774547
GPL8300
Ovarian cancer sample 32 Ovarian cancer overall survival (months): 58 overall survival (censored 1=event)): 0
GSM774548
GPL8300
Ovarian cancer sample 33 Ovarian cancer overall survival (months): 31 overall survival (censored 1=event)): 0
GSM774549
GPL8300
Ovarian cancer sample 34 Ovarian cancer overall survival (months): 59 overall survival (censored 1=event)): 0
GSM774550
GPL8300
Ovarian cancer sample 35 Ovarian cancer overall survival (months): 33 overall survival (censored 1=event)): 1
GSM774551
GPL8300
Ovarian cancer sample 36 Ovarian cancer overall survival (months): 50 overall survival (censored 1=event)): 0
GSM774552
GPL8300
Ovarian cancer sample 37 Ovarian cancer overall survival (months): 49 overall survival (censored 1=event)): 1
GSM774553
GPL8300
Ovarian cancer sample 38 Ovarian cancer overall survival (months): 23 overall survival (censored 1=event)): 0
GSM774554
GPL8300
Ovarian cancer sample 39 Ovarian cancer overall survival (months): 18 overall survival (censored 1=event)): 1
GSM774555
GPL8300
Ovarian cancer sample 40 Ovarian cancer overall survival (months): 65 overall survival (censored 1=event)): 0
GSM774556
GPL8300
Ovarian cancer sample 41 Ovarian cancer overall survival (months): 46 overall survival (censored 1=event)): 1
GSM774557
GPL8300
Ovarian cancer sample 42 Ovarian cancer overall survival (months): 61 overall survival (censored 1=event)): 0
GSM774558
GPL8300
Ovarian cancer sample 43 Ovarian cancer overall survival (months): 61 overall survival (censored 1=event)): 0
GSM774559
GPL8300
Ovarian cancer sample 44 Ovarian cancer overall survival (months): 51 overall survival (censored 1=event)): 0
GSM774560
GPL8300
Ovarian cancer sample 45 Ovarian cancer overall survival (months): 52 overall survival (censored 1=event)): 0
GSM774561
GPL8300
Ovarian cancer sample 46 Ovarian cancer overall survival (months): 33 overall survival (censored 1=event)): 1
GSM774562
GPL8300
Ovarian cancer sample 47 Ovarian cancer overall survival (months): 51 overall survival (censored 1=event)): 0
GSM774563
GPL8300
Ovarian cancer sample 48 Ovarian cancer overall survival (months): 52 overall survival (censored 1=event)): 0
GSM774564
GPL8300
Ovarian cancer sample 49 Ovarian cancer overall survival (months): 50 overall survival (censored 1=event)): 0
GSM774565
GPL8300
Ovarian cancer sample 50 Ovarian cancer overall survival (months): 44 overall survival (censored 1=event)): 0
GSM774566
GPL8300
Ovarian cancer sample 51 Ovarian cancer overall survival (months): 10 overall survival (censored 1=event)): 1
GSM774567
GPL8300
Ovarian cancer sample 52 Ovarian cancer overall survival (months): 26 overall survival (censored 1=event)): 1
GSM774568
GPL8300
Ovarian cancer sample 53 Ovarian cancer overall survival (months): 44 overall survival (censored 1=event)): 0
GSM774570
GPL8300
Ovarian cancer sample 55 Ovarian cancer overall survival (months): 12 overall survival (censored 1=event)): 1
GSM774571
GPL8300
Ovarian cancer sample 56 Ovarian cancer overall survival (months): 39 overall survival (censored 1=event)): 0
GSM774572
GPL8300
Ovarian cancer sample 57 Ovarian cancer overall survival (months): 30 overall survival (censored 1=event)): 1
GSM774573
GPL8300
Ovarian cancer sample 58 Ovarian cancer overall survival (months): 38 overall survival (censored 1=event)): 0
 
 
Make groups for comparisons
(2 groups will be compared at a time)
Select GSMs and click on "Add groups"
Enter the group name here:


Select expression type
Transcripts profile based on;
A. Differential status (Up/Down regulation)
B. Absolute calls (Transcribed/Not-detected)
 
Filter results by number of probes